000 | 01373 a2200409 4500 | ||
---|---|---|---|
005 | 20250514005418.0 | ||
264 | 0 | _c20010830 | |
008 | 200108s 0 0 eng d | ||
022 | _a1524-4571 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHoit, B D | |
245 | 0 | 0 |
_aTwo faces of nitric oxide: lessons learned from the NOS2 knockout. _h[electronic resource] |
260 |
_bCirculation research _cAug 2001 |
||
300 |
_a289-91 p. _bdigital |
||
500 | _aPublication Type: Comment; Editorial | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCalmodulin _xmetabolism |
650 | 0 | 4 |
_aCell Compartmentation _xphysiology |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 |
_aHeart _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
650 | 0 | 4 |
_aMyocardium _xenzymology |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide Synthase _xdeficiency |
650 | 0 | 4 | _aNitric Oxide Synthase Type I |
650 | 0 | 4 | _aNitric Oxide Synthase Type II |
650 | 0 | 4 | _aNitric Oxide Synthase Type III |
650 | 0 | 4 | _aOxidation-Reduction |
650 | 0 | 4 |
_aVasomotor System _xdrug effects |
650 | 0 | 4 |
_aVentricular Function, Left _xdrug effects |
650 | 0 | 4 |
_aVentricular Remodeling _xphysiology |
773 | 0 |
_tCirculation research _gvol. 89 _gno. 4 _gp. 289-91 |
|
999 |
_c11434166 _d11434166 |